{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T11:19:39Z","timestamp":1721128779873},"reference-count":28,"publisher":"Japan Atherosclerosis Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2015]]},"DOI":"10.5551\/jat.28886","type":"journal-article","created":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T22:32:25Z","timestamp":1422225145000},"page":"816-822","source":"Crossref","is-referenced-by-count":6,"title":["Significant Association between Serum Monokine Induced by Gamma Interferon and Carotid Intima Media Thickness"],"prefix":"10.5551","volume":"22","author":[{"given":"Hee Tae","family":"Yu","sequence":"first","affiliation":[{"name":"Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, KAIST"},{"name":"Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeewon","family":"Lee","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, KAIST"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eui-Cheol","family":"Shin","sequence":"additional","affiliation":[{"name":"Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, KAIST"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungha","family":"Park","sequence":"additional","affiliation":[{"name":"Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Epstein FH, Ross R: Atherosclerosis-an inflammat ory disease. N Engl J Med, 1999; 340: 115-126","DOI":"10.1056\/NEJM199901143400207"},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Robertson AK, Hansson GK: T Cells in AtherogenesisFor Better or For Worse? Arterioscler Thromb Vasc Biol, 2006; 26: 2421-2432","DOI":"10.1161\/01.ATV.0000245830.29764.84"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation, 2002; 105: 1135-1143","DOI":"10.1161\/hc0902.104353"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Zernecke A, Weber C: Chemokines in atheroscleros is: proceedings resumed. Arterioscler Thromb Vasc Biol, 2008; 28: 1897-1908","DOI":"10.1161\/ATVBAHA.107.161174"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD: Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest, 1999; 104: 1041-1050","DOI":"10.1172\/JCI6993"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Veillard NR, Steffens S, Pelli G, Lu B, Kwak BR, Gerard C, Charo IF, Mach F: Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo. Circulation, 2005; 112: 870-878","DOI":"10.1161\/CIRCULATIONAHA.104.520718"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Heller EA, Liu E, Tager AM, Yuan Q, Lin AY, Ahluwalia N, Jones K, Koehn SL, Lok VM, Aikawa E, Moore KJ, Luster AD, Gerszten RE: Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. Circulation, 2006; 113: 2301-2312","DOI":"10.1161\/CIRCULATIONAHA.105.605121"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Fernandes JL, Mamoni RL, Orford JL, Garcia C, Selwyn AP, Coelho OR, Blotta MH: Increased Th1 activity in patients with coronary artery disease. Cytokine, 2004; 26: 131-137","DOI":"10.1016\/j.cyto.2004.01.007"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) van Wanrooij EJ, de Jager SC, van Es T, de Vos P, Birch HL, Owen DA, Watson RJ, Biessen EA, Chapman GA, van Berkel TJ, Kuiper J: CXCR3 antagonist NBI-74330 attenuates atherosclerotic plaque formation in LDL receptor\u2013deficient mice. Arterioscler Thromb Vasc Biol, 2008; 28: 251-257","DOI":"10.1161\/ATVBAHA.107.147827"},{"key":"10","doi-asserted-by":"crossref","unstructured":"12) Gallo A, Saad A, Ali R, Dardik A, Tellides G, Geirsson A: Circulating interferon-\u03b3-inducible Cys-X-Cys chemokine receptor 3 ligands are elevated in humans with aortic aneurysms and Cys-X-Cys chemokine receptor 3 is necessary for aneurysm formation in mice. J Thorac Cardiovasc Surg, 2012; 143: 704-710","DOI":"10.1016\/j.jtcvs.2011.08.036"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Johnsen SH, Mathiesen EB: Carotid plaque compared with intima-media thickness as a predictor of coronary and cerebrovascular disease. Curr Cardiol Rep, 2009; 11: 21-27","DOI":"10.1007\/s11886-009-0004-1"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14) Libby P: Inflammation in atherosclerosis. Nature, 2002; 420: 868-874","DOI":"10.1038\/nature01323"},{"key":"13","doi-asserted-by":"crossref","unstructured":"15) Hansson GK: Regulation of immune mechanisms in atherosclerosis. Ann N Y Acad Sci, 2001; 947: 157-166","DOI":"10.1111\/j.1749-6632.2001.tb03938.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"16) Methe H, Brunner S, Wiegand D, Nabauer M, Koglin J, Edelman ER: Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol, 2005; 45: 1939-1945","DOI":"10.1016\/j.jacc.2005.03.040"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17) Harvey EJ, Ramji DP: Interferon-gamma and atherosclerosis: pro-or anti-atherogenic? Cardiovasc Res, 2005; 67: 11-20","DOI":"10.1016\/j.cardiores.2005.04.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"18) Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med, 1998; 187: 129-134","DOI":"10.1084\/jem.187.1.129"},{"key":"17","doi-asserted-by":"crossref","unstructured":"19) de Oliveira RT, Mamoni RL, Souza JR, Fernandes JL, Rios FJ, Gidlund M, Coelho OR, Blotta MH: Differen tial expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease. Int J Cardiol, 2009; 136: 17-26","DOI":"10.1016\/j.ijcard.2008.04.009"},{"key":"18","doi-asserted-by":"crossref","unstructured":"20) Xie JH, Nomura N, Lu M, Chen SL, Koch GE, Weng Y, Rosa R, Di Salvo J, Mudgett J, Peterson LB, Wicker LS, DeMartino JA: Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation. J Leukoc Biol, 2003; 73: 771-780","DOI":"10.1189\/jlb.1102573"},{"key":"19","doi-asserted-by":"crossref","unstructured":"21) Okamoto Y, Folco EJ, Minami M, Wara AK, Feinberg MW, Sukhova GK, Colvin RA, Kihara S, Funahashi T, Luster AD, Libby P: Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis. Circ Res, 2008; 102: 218-225","DOI":"10.1161\/CIRCRESAHA.107.164988"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22) Pauletto P, Palatini P, Da Ros S, Pagliara V, Santipolo N, Baccillieri S, Casiglia E, Mormino P, Pessina AC: Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol, 1999; 19: 1231-1237","DOI":"10.1161\/01.ATV.19.5.1231"},{"key":"21","doi-asserted-by":"crossref","unstructured":"23) Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, Nagai Y, Iyama S, Yamanishi H, Matsumoto M, Hori M: C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation, 2001; 104: 63-67","DOI":"10.1161\/hc2601.091705"},{"key":"22","doi-asserted-by":"crossref","unstructured":"24) Ohmori Y, Hamilton TA: Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma-and lipopolysaccharide-stimulated transcription from the murine IP-10 pro moter. J Biol Chem, 1993; 268: 6677-6688","DOI":"10.1016\/S0021-9258(18)53303-2"},{"key":"23","doi-asserted-by":"crossref","unstructured":"25) Hiroi M, Ohmori Y: Constitutive nuclear factor kappaB activity is required to elicit interferon-\u03b3-induced expression of chemokine CXC ligand 9 (CXCL9) and CXCL10 in human tumour cell lines. Biochem J, 2003; 376: 393-402","DOI":"10.1042\/bj20030842"},{"key":"24","doi-asserted-by":"crossref","unstructured":"26) Liu MT, K eirstead HS, Lane TE: Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol, 2001; 167: 4091-4097","DOI":"10.4049\/jimmunol.167.7.4091"},{"key":"25","doi-asserted-by":"crossref","unstructured":"27) Hsieh MF, Lai SL, Chen JP, Sung JM, Lin YL, Wu-Hsieh BA, Gerard C, Luster A, Liao F: Both CXCR3 and CXCL10\/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol, 2006; 177: 1855-1863","DOI":"10.4049\/jimmunol.177.3.1855"},{"key":"26","doi-asserted-by":"crossref","unstructured":"29) Salazar-Mather TP, Hamilton TA, Biron CA: A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest, 2000; 105: 985-993","DOI":"10.1172\/JCI9232"},{"key":"27","doi-asserted-by":"crossref","unstructured":"30) Menke J, Zeller GC, Kikawada E, Means TK, Huang XR, Lan HY, Lu B, Farber J, Luster AD, Kelley VR: CXCL9, but not CXCL10, promotes CXCR3-dependent immunemediated kidney disease. J Am Soc Nephrol, 2008; 19: 1177-1189","DOI":"10.1681\/ASN.2007111179"},{"key":"28","doi-asserted-by":"crossref","unstructured":"31) Zanchetti A, Hennig M, Hollweck R, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G: Baseline values but not treatment-induced changes in carotid intimamedia thickness predict incident cardiovascular events in treated hypertensive patients: findings in the European Lacidipine Study on Atherosclerosis (ELSA). Circulation, 2009; 120: 1084-1090","DOI":"10.1161\/CIRCULATIONAHA.108.773119"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/22\/8\/22_28886\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T16:09:26Z","timestamp":1651075766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/22\/8\/22_28886\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.28886","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}